WCBA
AVNS

Weaver C. Barksdale & Associates’s Avanos Medical AVNS Stock Holding History

Weaver C. Barksdale & Associates’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$9K Buy
189
+8
+4% +$368 0.01% 291
2017
Q3 		$8K Sell
181
-36
-17% -$1.54K 0.01% 303
2017
Q2 		$9K Sell
217
-12
-5% -$453 0.01% 278
2017
Q1 		$9K Hold
229
– – 0.01% 285
2016
Q4 		$8K Buy
229
+13
+6% +$465 0.01% 309
2016
Q3 		$7K Sell
216
-1
-0.5% -$35 0.01% 317
2016
Q2 		$7K Sell
217
-27
-11% -$827 0.01% 296
2016
Q1 		$7K Buy
244
+24
+11% +$639 0.01% 327
2015
Q4 		$7K Buy
220
+5
+2% +$155 0.01% 313
2015
Q3 		$6K Buy
215
+33
+18% +$1.15K ﹤0.01% 338
2015
Q2 		$7K Buy
182
+26
+17% +$1.17K 0.01% 323
2015
Q1 		$8K Sell
156
-25
-14% -$1.16K 0.01% 313
2014
Q4 		$8K Buy
+181
New +$7.11K 0.01% 296

Other funds holding AVNS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Weaver C. Barksdale & Associates's AVNS Position: Q4 2017 in Review

Weaver C. Barksdale & Associates increased its Avanos Medical (AVNS) stake by 4.4% in Q4 2017, buying an estimated $368 and bringing the position to 189 shares worth $9K. The position accounts for 0.01% of the portfolio, ranked #291.

Weaver C. Barksdale & Associates first reported a position in AVNS in Q4 2014 and has held it in 13 quarters since. 350 funds tracked by Wall St. Rank hold AVNS as of Q4 2017.

  • Weaver C. Barksdale & Associates held 189 shares of Avanos Medical worth $9K as of Q4 2017.
  • Weaver C. Barksdale & Associates bought 8 Avanos Medical shares in Q4 2017, an estimated $368.
  • Avanos Medical made up 0.01% of Weaver C. Barksdale & Associates's portfolio in Q4 2017, its #291 holding.
  • Weaver C. Barksdale & Associates first reported a position in Avanos Medical in Q4 2014 and has held it in 13 quarters since.
  • 350 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2017.

Based on Weaver C. Barksdale & Associates's 13F filing for Q4 2017, filed 10 Jan 2018.